PLEURAL MESOTHELIOMA - CLINICAL FEATURES AND THERAPEUTIC IMPLICATIONS

被引：137

作者：

LEGHA, SS ^{[1
]}

MUGGIA, FM ^{[1
]}

机构：

[1] NCI, DIV CANC TREATMENT, PROGRAM CANC THERAPY EVALUAT, BETHESDA, MD 20014 USA

来源：

关键词：

D O I：

10.7326/0003-4819-87-5-613

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：613 / 621

页数：9

共 98 条

[1] ARAI H, 1975, AM REV RESPIR DIS, V111, P699
[2] EPIDEMIOLOGICAL AND QUANTITATIVE RELATIONSHIPS BETWEEN MESOTHELIOMA AND ASBESTOS ON TYNESIDE
ASHCROFT, T
[J]. JOURNAL OF CLINICAL PATHOLOGY, 1973, 26 (11) : 832 - 840
[3] PERCENTAGE OF BENIGN AND MALIGN PLEURATUMORS AMONG PATIENTS OF A CLINIC OF LUNG SURGERY WITH SPECIAL CONSIDERATION OF MALIGN PLEURAMESOTHELIOMA AND ITS RADICAL TREATMENT, INCLUDING RESULTS OF A DIAPHRAGMA SUBSTITUTION OF PRESERVED DURA MATER
BAMLER, KJ
MAASSEN, W
[J]. THORAXCHIRURGIE VASKULARE CHIRURGIE, 1974, 22 (05): : 386 - 391
[4] BOGARDUS GM, 1955, AM REV TUBERC PULM, V71, P280
[5] MESOTHELIOMA FOLLOWING EXPOSURE TO ASBESTOS - REVIEW OF 72 CASES
BOROW, M
CONSTON, A
LIVORNES.L
SCHALET, N
[J]. CHEST, 1973, 64 (05) : 641 - 646
[6] TREATMENT OF PLEURAL MESOTHELIUM
BRINEY, WF
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 229 (02): : 141 - 141
[7] Cantarone G, 1975, Minerva Med, V66, P1300
[8] CASTLEMAN B, 1974, NEW ENGL J MED, V290, P152
[9] CASTOR CW, 1967, CANCER, V20, P462, DOI 10.1002/1097-0142(1967)20:3<462::AID-CNCR2820200315>3.0.CO
[10] 2-7